Skip to main content

9 Result(s)

within F Bouafia Remove this filter

and

  1. No Access

    Article

    Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma

    Rituximab, an anti-CD20 monoclonal antibody, is increasingly used in the treatment of B-cell non-Hodgkin's lymphoma. Late-onset neutropenia in relation to rituximab has been recently described. In this report,...

    B Lemieux, S Tartas, C Traulle, D Espinouse, C Thieblemont… in Bone Marrow Transplantation (2004)

  2. No Access

    Article

    Autoimmune thrombocytopenic purpura after autologous stem cell transplantation

    The pathogenesis of thrombocytopenia occurring after autologous stem cell transplantation (ASCT) remains unclear. Six cases of classical peripheral thrombocytopenia that developed after ASCT for non-Hodgkin's ...

    O Hequet, G Salles, N Ketterer, D Espinouse, C Dumontet… in Bone Marrow Transplantation (2003)

  3. No Access

    Article

    Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma

    High-dose melphalan (HDM) has been adopted as standard therapy in the treatment of multiple myeloma. This treatment is associated with non-selective cytotoxicity, causing oral mucositis as the major non-hemato...

    C Thieblemont, C Dumontet, H Saad, N Roch, F Bouafia… in Bone Marrow Transplantation (2002)

  4. No Access

    Article

    Multifocal progressive leukoencephalopathy occurring after refractory anemia and multiple infectious disorders consecutive to severe lymphopenia

    Progressive multifocal leukoencephalopathy (PML) is related to central nervous system infection with JC virus (JCV). This leukoencephalopathy occurs in immunocompromised patients such as those with acquired i...

    O. Hequet, G. Salles, D. Espinousse, C. Dumontet, F. Bouafia… in Annals of Hematology (2002)

  5. No Access

    Article

    Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma

    Bone Marrow Transplantation (2002) 29, 544. doi:10.1038/sj.bmt.1703383

    O Hequet, C Dumontet, A El Jaafari-Corbin, G Salles… in Bone Marrow Transplantation (2002)

  6. No Access

    Article

    A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors

    Patients with nhl and two or three factors of the international prognostic index (ipi) have a poor prognosis. we performed a prospective trial of intensive induction therapy followed with high-dose consolidati...

    C Dumontet, C Thieblemont, D Espinouse, F Bouafia, O Hequet, G Salles… in Leukemia (2000)

  7. No Access

    Article

    Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution

    Two hundred and seventy-seven consecutive patients with non-Hodgkin’s lymphoma (n = 207), Hodgkin’s disease (n = 27) and multiple myeloma (n = 43) were intensified from October 1989 until April 1997 and received ...

    N Ketterer, A Sonet, C Dumontet, I Moullet, C Thieblemont… in Bone Marrow Transplantation (1999)

  8. No Access

    Article

    Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin’s lymphoma

    Serum lactic dehydrogenase (LDH) is an important prognostic factor in patients with non-Hodgkin’s lymphoma (NHL). We have examined the LDH isoenzyme content in serum and CSF of patients with NHL, at diagnosis ...

    C Dumontet, J Drai, J Bienvenu, E Neidhardt Berard, C Thieblemont, F Bouafia… in Leukemia (1999)

  9. No Access

    Article

    Mantle cell lymphoma: a retrospective study of 121 cases

    Mantle cell lymphoma (MCL) patients represent a difficult problem, sometimes to establish the diagnosis but mostly because of their refractoriness to standard lymphoma treatments. Which treatments to apply and...

    H Samaha, C Dumontet, N Ketterer, I Moullet, C Thieblemont, F Bouafia… in Leukemia (1998)